Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
In hepatitis B virus (HBV) infection, the interplay between the virus and the host immune system is crucial in determining the pathogenesis of the disease. Patients who fail to mount a sufficient and sustained anti-viral immune response develop chronic hepatitis B (CHB). T cells and natural killer (...
Main Authors: | Lucile Dumolard, Caroline Aspord, Patrice N. Marche, Zuzana Macek Jilkova |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1148111/full |
Similar Items
-
Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
by: Zuzana Macek Jilkova, et al.
Published: (2019-10-01) -
Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” <em>Cancers</em> 2019, <em>11</em>, 1554
by: Zuzana Macek Jilkova, et al.
Published: (2020-09-01) -
Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation
by: Johan Noble, et al.
Published: (2024-03-01) -
Prospects for NK-based immunotherapy of chronic HBV infection
by: Xiaomeng Jin, et al.
Published: (2022-12-01) -
Gamma delta T cells in hepatocellular carcinoma: Sunrise of new therapy based on Vδ2 T cells?
by: Zuzana Macek Jilkova
Published: (2022-04-01)